Indian Drugmaker Taps Private Credit for Japanese Acquisition

Indian drugmaker Gujarat Themis Biosyn Ltd. has secured private credit funding to back its acquisition of Japanese peer MicroBiopharm Japan Co. The deal highlights the growing use of private credit for overseas expansion in Asia, as companies seek alternative financing beyond traditional bank loans.